Evidence Report/Technology Assessment Number 12

Management of New Onset Atrial Fibrillation

File Inventory


Prepared by:

Johns Hopkins University, Baltimore, MD
Robert L. McNamara, M.D., M.H.S.
   Principal Investigator
Eric B. Bass, M.D., M.P.H.
   Co-Principal Investigator
Marlene R. Miller, M.D.
Jodi B. Segal, M.D., M.P.H.
Steven N. Goodman, M.D., Ph.D.
Nina L. Kim, M.A.
Karen A. Robinson, M.Sc.
Neil R. Powe, M.D., M.P.H., M.B.A.
   Investigators


File Name		Description			Software	Version		File	Size
__________________________________________________________________________________________________________
01front.doc		Microsoft Word® Document	MS Word®	97 SR-1		49KB	12 pages
Contents: Title Page, Preface, Structured Abstract, Table of Contents
__________________________________________________________________________________________________________
02body.doc		Microsoft Word® Document	MS Word®	97 SR-1		714KB	175 pages
Contents: Summary, Chapter 1. Introduction, Chapter 2. Methodology, Chapter 3. Results, 
Chapter 4. Conclusions, Chapter 5. Future Research, Chapter 6. Decision Analysis, 
References
__________________________________________________________________________________________________________
03etab1.doc		Microsoft Word® Document	MS Word®	97 SR-1		130KB	8 pages
Contents: Evidence table 1. Design Characteristics of Studies on Pharmacological Conversion 
(Alone and in Conjunction with Direct Current Cardioversion) of Atrial Fibrillation
__________________________________________________________________________________________________________
04etab2.doc		Microsoft Word® Document	MS Word®	97 SR-1		83KB	6 pages
Contents: Evidence table 2. Design Characteristics of Studies on Pharmacological 
Maintenance of Sinus Rhythm in Atrial Fibrillation
__________________________________________________________________________________________________________
05etab3.doc		Microsoft Word® Document	MS Word®	97 SR-1		138KB	8 pages
Contents: Evidence table 3. Results of Studies on Pharmacological Conversion 
of Atrial Fibrillation
__________________________________________________________________________________________________________
06etab4.doc		Microsoft Word® Document	MS Word®	97 SR-1		45KB	2 pages
Contents: Evidence table 4. Results of Studies on Pharmacological Conversion 
in Conjunction with Direct Current Cardioversion of Atrial Fibrillation
__________________________________________________________________________________________________________
07etab5.doc		Microsoft Word® Document	MS Word®	97 SR-1		99KB	5 pages
Contents: Evidence table 5. Results of Studies on Pharmacological Maintenance 
of Sinus Rhythm in Atrial Fibrillation
__________________________________________________________________________________________________________
08etab6a.doc		Microsoft Word® Document	MS Word®	97 SR-1		42KB	2 pages
Contents: Evidence table 6A. Design of Placebo-Controlled Trials of Calcium-Channel-Blockers 
for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
09etab6b.doc		Microsoft Word® Document	MS Word®	97 SR-1		47KB	2 pages
Contents: Evidence table 6B. Design of Placebo-Controlled Trials of Beta-Blockers 
for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
10etab6c.doc		Microsoft Word® Document	MS Word®	97 SR-1		54KB	4 pages
Contents: Evidence table 6C. Design of Placebo-Controlled Trials of Other Drugs and 
Combinations for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
11etab6d.doc		Microsoft Word® Document	MS Word®	97 SR-1		41KB	2 pages
Contents: Evidence table 6D. Design of Trials Comparing Calcium-Channel-Blockers 
to Digoxin for Rate Control for Atrial Fibrillation
__________________________________________________________________________________________________________
12etab6e.doc		Microsoft Word® Document	MS Word®	97 SR-1		34KB	1 page
Contents: Evidence table 6E. Design of Trials Comparing Beta-Blockers to Digoxin 
for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
13etab6f.doc		Microsoft Word® Document	MS Word®	97 SR-1		62KB	4 pages
Contents: Evidence table 6F. Design of Digoxin-Controlled Trials of Other Drugs 
or Combinations for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
14etab6g.doc		Microsoft Word® Document	MS Word®	97 SR-1		42KB	2 pages
Contents: Evidence table 6G. Design of Trials Comparing Other Drugs for Rate Control 
in Atrial Fibrillation
__________________________________________________________________________________________________________
15etab7a.doc		Microsoft Word® Document	MS Word®	97 SR-1		42KB	2 pages
Contents: Evidence table 7A. Results of Placebo-Controlled Trials of 
Calcium-Channel-Blockers for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
16etab7b.doc		Microsoft Word® Document	MS Word®	97 SR-1		43KB	3 pages
Contents: Evidence table 7B. Results of Placebo-Controlled Trials of Beta-Blockers 
for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
17etab7c.doc		Microsoft Word® Document	MS Word®	97 SR-1		47KB	4 pages
Contents: Evidence table 7C. Results of Placebo-Controlled Trials of Other Drugs 
or Combinations for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
18etab7d.doc		Microsoft Word® Document	MS Word®	97 SR-1		36KB	2 pages
Contents: Evidence table 7D. Results of Trials Comparing Calcium-Channel-Blockers 
to Digoxin for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
19etab7e.doc		Microsoft Word® Document	MS Word®	97 SR-1		31KB	2 pages
Contents: Evidence table 7E. Results of Trials Comparing Beta-Blockers to Digoxin 
for Rate Control in Atrial Fibrillation
__________________________________________________________________________________________________________
20etab7f.doc		Microsoft Word® Document	MS Word®	97 SR-1		54KB	5 pages
Contents: Evidence table 7F. Results of Digoxin-Controlled Trials of Other Drugs 
or Combinations for Rate Control for Atrial Fibrillation
__________________________________________________________________________________________________________
21etab7g.doc		Microsoft Word® Document	MS Word®	97 SR-1		36KB	2 pages
Contents: Evidence table 7G. Results of Trials Comparing Other Drugs for Rate Control 
in Atrial Fibrillation
__________________________________________________________________________________________________________
22etab8.doc		Microsoft Word® Document	MS Word®	97 SR-1		47KB	3 pages
Contents: Evidence table 8.  Designs of Studies of Antithrombotic Therapies 
for Patients with Atrial Fibrillation
__________________________________________________________________________________________________________
23etab9.doc		Microsoft Word® Document	MS Word®	97 SR-1		61KB	4 pages
Contents: Evidence table 9. Results of Studies of Antithrombotic Therapies 
for Patients with Atrial Fibrillation
__________________________________________________________________________________________________________
24efigs.doc		Microsoft Word® Document	MS Word®	97 SR-1		3.3MB	70 pages
Contents: Figures 1 through 62
__________________________________________________________________________________________________________
25biblio.doc		Microsoft Word® Document	MS Word®	97 SR-1		197KB	36 pages
Contents: Bibliography
__________________________________________________________________________________________________________
26appa.doc		Microsoft Word® Document	MS Word®	97 SR-1		37KB	4 pages
Contents: Appendix A. Technical Experts for Evidence Report on Management of 
Atrial Fibrillation
__________________________________________________________________________________________________________
27appb.doc		Microsoft Word® Document	MS Word®	97 SR-1		49KB	4 pages
Contents: Appendix B. Questionnaire Regarding New Onset Atrial Fibrillation 
__________________________________________________________________________________________________________
28appc.doc		Microsoft Word® Document	MS Word®	97 SR-1		76KB	2 pages
Contents: Appendix C. Causal Pathway of Atrial Fibrillation
__________________________________________________________________________________________________________
29appd.doc		Microsoft Word® Document	MS Word®	97 SR-1		35KB	2 pages
Contents: Appendix D. Overall Topic Search Strategy for CENTRAL and MEDLINE
__________________________________________________________________________________________________________
30appe.doc		Microsoft Word® Document	MS Word®	97 SR-1		36KB	2 pages
Contents: Appendix E. Cochrane Optimal Search Strategy for Retrieval of Controlled Trials
__________________________________________________________________________________________________________
31appf.doc		Microsoft Word® Document	MS Word®	97 SR-1		36KB	2 pages
Contents: Appendix F. Additional Search Strategy for Key Question 4
__________________________________________________________________________________________________________
32appg.doc		Microsoft Word® Document	MS Word®	97 SR-1		36KB	2 pages
Contents: Appendix G. Additional Search Strategy for Key Question 5
__________________________________________________________________________________________________________
33apph.doc		Microsoft Word® Document	MS Word®	97 SR-1		40KB	2 pages
Contents: Appendix H. Abstract Review Form
__________________________________________________________________________________________________________
34appi.doc		Microsoft Word® Document	MS Word®	97 SR-1		119KB	26 pages
Contents: Appendix I. Article Review Form
__________________________________________________________________________________________________________
35appj.doc		Microsoft Word® Document	MS Word®	97 SR-1		127KB	18 pages
Contents: Appendix J. Article Review Form
__________________________________________________________________________________________________________
36appk.doc		Microsoft Word® Document	MS Word®	97 SR-1		37KB	2 pages
Contents: Appendix K. List of Journals Cited More Than Twice in Atrial Fibrillation Database 
as of April 2, 1998, Used for REVEAL Service
__________________________________________________________________________________________________________
37appl.doc		Microsoft Word® Document	MS Word®	97 SR-1		37KB	2 pages
Contents: Appendix L. Abstract Review
__________________________________________________________________________________________________________
38appm.doc		Microsoft Word® Document	MS Word®	97 SR-1		38KB	2 pages
Contents: Appendix M. Article Review
__________________________________________________________________________________________________________
39appn.doc		Microsoft Word® Document	MS Word®	97 SR-1		42KB	4 pages
Contents: Appendix N. Summary of Abstract Review Disagreements Between Reviewers
__________________________________________________________________________________________________________
40appo.doc		Microsoft Word® Document	MS Word®	97 SR-1		40KB	2 pages
Contents: Appendix O. Articles Identified Too Late for Inclusion in Evidence Synthesis
__________________________________________________________________________________________________________
41appp.doc		Microsoft Word® Document	MS Word®	97 SR-1		85KB	2 pages
Contents: Appendix P. Subgroup Analysis
__________________________________________________________________________________________________________

AHRQ Publication No. 01-E026
Current as of January 2001


Internet Citation:

Management of New Onset Atrial Fibrillation. File Inventory, Evidence Report/Technology Assessment Number 12. AHRQ Publication No. 01-E026, January 2001. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/atfibinv.htm


Return to Evidence-based Practice
Clinical Information
AHRQ Home Page
Department of Health and Human Services